![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
最近在治疗高级系统性巨细胞瘤的治疗管理方面的进展
Scott Veitch1, Deepti H Radia1
1Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK.
Diagnostics (Basel, Switzerland)
|January 11, 2024
概括
先进的全身性巨细胞瘤 (AdvSM) 治疗改善了结果. 氨酸激酶抑制剂 (TKIs) 为患有这种罕见癌症的患者提供分子缓解,更好的生活质量和生存.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 先进的全身性巨细胞瘤 (AdvSM) 是一种罕见的,侵袭性的血液性瘤.
- 新生性巨细胞 (MC) 积累导致器官功能障碍和生存率降低.
- 在AdvSM中,KIT D816V突变是常见的.
研究的目的:
- 审查目前针对AdvSM的向治疗方法.
- 突出新兴的治疗目标和策略.
- 讨论对这种异质性疾病的管理.
主要方法:
- 在临床实践中针对性治疗的审查.
- 在AdvSM的临床试验中对药物的分析.
- 讨论未来的治疗方向.
主要成果:
- 氨酸激酶抑制剂 (TKI) 已经改变了AdvSM的治疗方法.
- 患者可以实现分子缓解和改善生存率.
- 有针对性的疗法可以改善生活质量.
结论:
- 针对性疗法代表了AdvSM管理的重大进步.
- 目前正在进行的研究正在确定新的治疗点.
- 个性化策略对于这种复杂的疾病至关重要.
更多相关视频
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.3K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.4K
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K